CD4+ T

Masahiro Kiuchi1, Masahiro Nemoto1, Hiroyuki Yagyu1,2

  • 1Department of Immunology, Graduate School of Medicine, Chiba University, Chuo-ku, Chiba, Japan.

Science (New York, N.Y.)
|December 11, 2025
PubMed
概括

肝白血病因子 (HLF) 被确定为CD4+组织内存T (TRM) 细胞的关键调节剂. 这一发现揭示了HLF在指导TRM细胞发育和促进炎症方面的作用.